{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:26:49Z","timestamp":1784690809840,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.radonc.2026.111546","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:03:34Z","timestamp":1776899014000},"page":"111546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cardiac adverse events following post-operative radiation therapy in patients with thymic malignancies"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9857-877X","authenticated-orcid":false,"given":"O.","family":"Icht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7995-789X","authenticated-orcid":false,"given":"I.","family":"Nardi-Agmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Miro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Badran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Keshavjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2583-6974","authenticated-orcid":false,"given":"X.Y.","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-2367","authenticated-orcid":false,"given":"T.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4531-3396","authenticated-orcid":false,"given":"B.C.J.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bezjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Thavendiranathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8536-3908","authenticated-orcid":false,"given":"I.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7797-2893","authenticated-orcid":false,"given":"T.","family":"Tadic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111546_b0005","doi-asserted-by":"crossref","unstructured":"Li X, Wu Y, Wang Q, Li B, Wang J. Radiation-induced cardiac substructure damage and dose constraints: a review. Radiat Oncol. 2025;20(1):94. Published 2025 Jun 5. doi:10.1186\/s13014-025-02668-x.","DOI":"10.1186\/s13014-025-02668-x"},{"key":"10.1016\/j.radonc.2026.111546_b0010","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.radonc.2026.111546_b0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41416-024-02888-0","article-title":"Cardiotoxicity following thoracic radiotherapy for lung cancer","volume":"132","author":"Walls","year":"2025","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2026.111546_b0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijrobp.2023.08.011","article-title":"Incident atrial fibrillation and survival outcomes in esophageal cancer following radiotherapy","volume":"118","author":"Miller","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111546_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110544","article-title":"Prediction of new-onset atrial fibrillation in patients with non-small cell lung cancer treated with curative-intent conventional radiotherapy","volume":"201","author":"Tohidinezhad","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111546_b0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/jamaoncol.2020.6332","article-title":"Association of left anterior descending coronary artery radiation dose with major adverse cardiac events and mortality in patients with non-small cell lung cancer","volume":"7","author":"Atkins","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2026.111546_b0035","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.ijrobp.2021.03.004","article-title":"The importance of radiation dose to the atherosclerotic plaque in the left anterior descending coronary artery for radiation-induced cardiac toxicity of breast cancer patients?","volume":"110","author":"van den Bogaard","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111546_b0040","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijrobp.2022.04.019","article-title":"Dose to the left anterior descending artery correlates with cardiac events after irradiation for breast cancer","volume":"114","author":"Zureick","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111546_b0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.21037\/med-24-10","article-title":"State of the art in radiation therapy for thymic malignancies: extended abstract","volume":"8","author":"Simone","year":"2024","journal-title":"Mediastinum"},{"key":"10.1016\/j.radonc.2026.111546_b0050","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111546_b0055","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.cllc.2016.05.019","article-title":"Adjuvant proton beam therapy in the management of thymoma: a dosimetric comparison and acute toxicities","volume":"17","author":"Parikh","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2026.111546_b0060","doi-asserted-by":"crossref","unstructured":"Loap P, Scher N, Goudjil F, Kirova Y, Girard N, Cao KI. Proton beam therapy for thymic carcinoma with pericardial involvement. Int J Part Ther. 2020;7(3):65-70. Published 2020 Nov 16. doi:10.14338\/IJPT-20-00023.1.","DOI":"10.14338\/IJPT-20-00023.1"},{"key":"10.1016\/j.radonc.2026.111546_b0065","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.radonc.2016.02.003","article-title":"Prospective study of proton beam radiation therapy for adjuvant and definitive treatment of thymoma and thymic carcinoma: early response and toxicity assessment","volume":"118","author":"Vogel","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111546_b0070","article-title":"The risk of cardiovascular adverse outcomes in patients with thymoma or thymic carcinoma receiving cancer therapy","author":"Agmon","year":"2026","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2026.111546_b0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s13246-023-01231-w","article-title":"Open-source, fully-automated hybrid cardiac substructure segmentation: development and optimisation","volume":"46","author":"Finnegan","year":"2023","journal-title":"Phys Eng Sci Med"},{"key":"10.1016\/j.radonc.2026.111546_b0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thorsurg.2010.08.001","article-title":"Management of stage I and II thymoma","volume":"21","author":"Detterbeck","year":"2011","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.radonc.2026.111546_b0085","doi-asserted-by":"crossref","unstructured":"Tomita N, Okuda K, Ogawa Y, et al. Relationship between radiation doses to heart substructures and radiation pneumonitis in patients with thymic epithelial tumors. Sci Rep 2020;10(1):11191. Published 2020 Jul 7. doi:10.1038\/s41598-020-68168-y.","DOI":"10.1038\/s41598-020-68168-y"},{"key":"10.1016\/j.radonc.2026.111546_b0090","doi-asserted-by":"crossref","unstructured":"Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group. Lancet. 1998;352(9124):257-263. doi: 10.1016\/S0140-6736(98)06341-7.","DOI":"10.1016\/S0140-6736(98)06341-7"},{"key":"10.1016\/j.radonc.2026.111546_b0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1470-2045(21)00606-9","article-title":"Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (lung ART): an open-label, randomised, phase 3 trial","volume":"23","author":"Le Pechoux","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111546_b0100","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.radonc.2022.05.007","article-title":"Exposure of the heart in lung cancer radiation therapy: a systematic review of heart doses published during 2013 to 2020","volume":"172","author":"Kearney","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111546_b0105","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.jacc.2019.03.500","article-title":"Cardiac radiation dose, cardiac disease, and mortality in patients with lungcancer","volume":"73","author":"Atkins","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.radonc.2026.111546_b0110","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111546_b0115","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.ijrobp.2021.03.005","article-title":"Mean heart dose is an inadequate surrogate for left anterior descending coronary artery dose and the risk of major adverse cardiac events in lung cancer radiation therapy","volume":"110","author":"Atkins","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111546_b0120","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jamaoncol.2022.4202","article-title":"Association of sinoatrial node radiation dose with atrial fibrillation and mortality in patients with lung cancer","volume":"8","author":"Kim","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2026.111546_b0125","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.radonc.2017.04.017","article-title":"Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients","volume":"123","author":"Stam","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111546_b0130","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1200\/JCO.2016.69.8480","article-title":"Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures","volume":"35","author":"van den Bogaard","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111546_b0135","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood-2016-09-740332","article-title":"Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines","volume":"129","author":"van Nimwegen","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2026.111546_b0140","doi-asserted-by":"crossref","unstructured":"Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the childhood cancer survivor study cohort. BMJ. 2009;339:b4606. Published 2009 Dec 8. doi:10.1136\/bmj.b4606.","DOI":"10.1136\/bmj.b4606"},{"key":"10.1016\/j.radonc.2026.111546_b0145","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ijrobp.2025.06.3852","article-title":"Differential impact of left ventricular myocardium and left coronary radiation dose with incident heart failure and coronary events in lung cancer radiation therapy","volume":"123","author":"Zhang","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111546_b0150","doi-asserted-by":"crossref","unstructured":"Marzo AM, Cozzi L, Franceschini D, et al. Cardiac exposure related to adjuvant radiotherapy in patients affected by thymoma: a dosimetric comparison of photon or proton intensity-modulated therapy. Cancers (Basel). 2025;17(2):294. Published 2025 Jan 17. doi:10.3390\/cancers17020294.","DOI":"10.3390\/cancers17020294"},{"key":"10.1016\/j.radonc.2026.111546_b0155","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/0284186X.2017.1302097","article-title":"Risk of major cardiac events following adjuvant proton versus photon radiation therapy for patients with thymic malignancies","volume":"56","author":"Vogel","year":"2017","journal-title":"Acta Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026003853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026003853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:45:46Z","timestamp":1783169146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026003853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"alternative-id":["S0167814026003853"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111546","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac adverse events following post-operative radiation therapy in patients with thymic malignancies","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111546"}}